Whether you’re following a specific Ulcerative Colitis diet or trying to manage symptoms through an anti-inflammatory diet, Evinature’s protocol is designed to support your efforts. Our natural, research-backed compounds work alongside your dietary habits, helping you achieve faster remission and maintain long-term results—without needing to change your existing diet.
The latest research shows that using clinically tested natural compounds like Curcumin & Qing Dai (QD) can induce remission quickly, so you can recover as soon as possible and maintain long-term remission. Best of all, these natural treatments can complement your current diet for colitis flare-ups or remission-sustaining IBD diet, without interfering with your dietary choices.
This integrative protocol targets numerous underlying mechanisms involved in IBD with an aim to prevent future flares and get you into long-term, sustainable remission—all while supporting any ulcerative colitis diet you may be following.
Our goal is to empower you to manage your colitis in the most effective way possible. Although we don’t provide diet plans, our protocol is designed to complement your chosen dietary approach, whether you are focusing on an anti-inflammatory diet or any other approach to manage your symptoms.
Our Story
We’re a collective of gastro doctors & clinicians who want to change the way colitis patients find relief. We’ve witnessed too many of our patients suffer years of treatment only to see minimal or inadequate results.
We knew there had to be a better way; we just had to find it.
We wound up in the Far East, where we conferred with herbalists in China, Hong Kong & India. From the thousands of herbs used traditionally, two stood out: curcumin and qing-dai (QD), both used for inflammatory and digestive conditions.
These herbs needed to be optimized for our ulcerative colitis patients, so we brought them back to our lab, and after months of development, we began integrating them in our clinics.
The change was immediate. Hundreds of our patients found the relief they were looking for, and have maintained it to this day.
We had a duty to share this information with the world, so we designed a clinical trial in collaboration with colleagues from around the world who shared our vision. Together, we launched a multi-center, randomized, double-blind, placebo-controlled clinical trial to officially confirm what we were seeing in our clinics.
The results were more successful than even we could believe. This trial used a combination of curcumin with qing dai (CurQD®) on ulcerative colitis patients who had all failed at least one line of pharmaceutical colitis medication for 8 weeks.
At week 8, 50% of UC patients achieved clinical remission, and 85.7% achieved clinical response.
We also found that tailoring the formula to the patient significantly improved symptom relief and remission rates. So we created customized formulas to target each stage of disease severity, including during flare-ups.
Whether you’re suffering severe symptoms or seeking a natural approach to prevent relapse, we have a protocol for you.
It doesn’t have to be chronic
In a retrospective study on CurQD® accepted and presented at the United European Gastroenterology conference in Vienna, researchers analyzed the data of difficult-to-treat ulcerative colitis patients referred from 5 top medical centers in Israel.
All UC patients had severe disease activity and were not responding to biologics (46%), corticosteroids (41.5%), or biologics/small molecule therapy (31.1%).
After 8-12 weeks on CurQD®, 50% of patients achieved clinical remission, and 85.7% achieved clinical response.
CurQD® was found greatly superior to placebo for induction of response and remission in active colitis patients, including in patients with moderate-severely active UC, of whom half were biologics or immuno-modulators experienced.
A limited CurQD® induction phase followed by curcumin maintenance appeared to maximize the efficacy and safety of this combination therapy.
You don’t have to just take our word for it. Here’s what our own patients have to say.
1w
2
3
